Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.
Press releases published on April 8, 2025
Clene Presents Evidence of Remyelination and Neuronal Repair With CNM-Au8® Treatment At the American Academy of Neurology Late-Breaking Science Session
GlobeNewswire
·
April 8, 2025
Analyses of MRI and VEP data confirm anatomical and physiological improvements, indicating remyelination and neuronal repair in the brains of MS patients treated with CNM-Au8 during the long-term extension of VISIONARY-MS Over 90% of participants who …
Praxis Precision Medicines to Hold Virtual Investor Event to Discuss Clinical Programs in Developmental and Epileptic Encephalopathies
GlobeNewswire
·
April 8, 2025
BOSTON, April 08, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized …
Opus Genetics Announces One-Month Clinical Data from Pediatric Patient in Phase 1/2 Trial of OPGx-LCA5 Gene Therapy in Inherited Retinal Diseases
GlobeNewswire
·
April 8, 2025
First pediatric patient shows encouraging early safety profile and meaningful improvement in visual function at one month A second pediatric patient was recently dosed, and the pediatric cohort is expected to complete enrollment in Q2 2025; initial data …
ProStar Announces Global Commercial Strategy with Radiodetection to Deliver Precision Utility Mapping
GlobeNewswire
·
April 8, 2025
GRAND JUNCTION, Colo., April 08, 2025 (GLOBE NEWSWIRE) -- ProStar® Holdings Inc., (“ProStar®” or “the Company”) (TSXV: MAPS) (OTCQX: MAPPF) (FSE: 5D00) the developers of PointMan®, Precision Mapping Solutions® is pleased to announce a Global Commercial …
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma
GlobeNewswire
·
April 8, 2025
SEATTLE, April 08, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease …
Cycurion, Inc. Expands Partnership with Journal Technologies, Secures $22 Million Contract with State Police Agency
GlobeNewswire
·
April 8, 2025
FALLS CHURCH, Va., April 08, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU), a trailblazer in advanced cybersecurity and information technology solutions, today announces an expanded partnership with Journal Technologies, a leading provider of case …
Recursion Announces First Patient Dosed in Phase 1 Clinical Study of REC-3565, a Selective MALT1 Inhibitor for Relapsed or Refractory B-cell Lymphomas
GlobeNewswire
·
April 8, 2025
Salt Lake City, UT, April 08, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that the first patient has been dosed in the Phase 1 EXCELERIZE clinical …
TransGlobal Assets Inc. (OTC: TMSH) Set to Transform Fintech and Dating with AI-Powered Platforms: Intelligent Debt Solutions and DateGuard
GlobeNewswire
·
April 8, 2025
AI-First Debt Solutions That Prioritize Human Wellness: Intelligent Debt Solutions leverages real-time behavioral analytics and ethical AI to offer highly personalized financial recovery pathways for individuals while boosting efficiency and empathy in …
OilXCoin's Prospectus Secures First Regulatory Approval For A Very Unique Security Token Backed by Oil & Gas
GlobeNewswire
·
April 8, 2025
Geneva, Switzerland, April 08, 2025 (GLOBE NEWSWIRE) -- The Financial Market Authority (FMA) in Liechtenstein has approved the security prospectus for OilXCoin for offering in key EEA jurisdictions and establishing its presence in the Real-World Asset (RWA …
Jupiter Neurosciences Highlights Upcoming Milestones in Shareholder Letter
GlobeNewswire
·
April 8, 2025
Strategic expansion into longevity market creates near-term commercial opportunity alongside continued clinical advancement of JOTROL™ JOTROL™ development programs remain tariff-exempt; consumer longevity line on track with negligible cost exposure Jupiter …
XRPTurbo Launches $XRT Token On Bitmart, Set To Release Liquid Staking Platform & Upcoming Launchpad
GlobeNewswire
·
April 8, 2025
TALLINN, Estonia, April 08, 2025 (GLOBE NEWSWIRE) -- XRPTurbo, the first AI …
SIGA Declares Special Cash Dividend of $0.60 Per Share
GlobeNewswire
·
April 8, 2025
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that its board of directors declared a special cash dividend of $0.60 per share on the company’s common …
Repligen Appoints Jacob Johnson As Vice President Investor Relations
GlobeNewswire
·
April 8, 2025
WALTHAM, Mass., April 08, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced the appointment of Jacob Johnson as Vice President, Investor Relations. In this role, Mr. Johnson will lead the investor relations team’s engagement with …
Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance
GlobeNewswire
·
April 8, 2025
‒ Q1 2025 Unaudited Net Revenue of $39.0 million ‒ ‒ Expected Q1 Adjusted EBITDA above $22.5 million ‒ ‒ Q1 2025 Cash and Cash Equivalents of Approximately $77.5 million ‒ BERKELEY HEIGHTS, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: …
ZenaDrone Expands Domestic Manufacturing for US Commercial Customers and US Defense Without Needing to Increase Prices
GlobeNewswire
·
April 8, 2025
VANCOUVER, British Columbia, April 08, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), enterprise SaaS and …
Gaxos Health Announces Launch of AI-Powered App
GlobeNewswire
·
April 8, 2025
Roseland, NJ, April 08, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced the official launch of the AI-enabled Gaxos Health mobile …
Kura Oncology and Kyowa Kirin Announce Submission of New Drug Application for Ziftomenib to FDA
GlobeNewswire
·
April 8, 2025
SAN DIEGO and TOKYO, April 08, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA, “Kura”), and Kyowa Kirin Co., Ltd. (TSE: 4151, “Kyowa Kirin”), today announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once- …
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
GlobeNewswire
·
April 8, 2025
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the American Academy of …
EvolveImmune Therapeutics Announces Translational Research Collaboration to Evaluate Expression of Novel Tumor Target in Muscle-Invasive Bladder Cancer
GlobeNewswire
·
April 8, 2025
BRANFORD, Conn. and NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- EvolveImmune Therapeutics, an immuno-oncology company developing next-generation T cell engager biotherapeutics to overcome cancer cell resistance to current immunotherapies, today announced …
Comanche Biopharma Announces European Medicines Agency (EMA) Has Granted Orphan Drug Designation for CBP-4888 in sFlt1-mediated Preterm Preeclampsia
GlobeNewswire
·
April 8, 2025
EMA orphan drug designation is awarded to drugs intended to treat rare diseases that are life-threatening or chronically debilitating Preeclampsia, a serious obstetric complication, is a leading cause of near-term morbidity and mortality for mothers and …